Article

Episode 2: Embracing AI in DR, glaucoma and at the podium

In Part 2 of this EyePod episode, Rohit Varma, MD, founding director of the newly formed Southern California Eyecare and Vision Research Institute, continues the discussion on artificial intelligence (AI) and its increasing presence in diabetic retinopathy (DR) and glaucoma-and at the podium.

Also available on iTunes.

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
Related Content
Bascom Palmer Eye Institute ranked as top ophthalmology hospital in US for 22nd year in a row
July 29th 2025

Bascom Palmer Eye Institute ranked as top ophthalmology hospital in US for 22nd year in a row

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Re-Vana and Boehringer Ingelheim launch $1B collaboration to develop extended-release eye therapies
July 28th 2025

Re-Vana and Boehringer Ingelheim launch $1B collaboration to develop extended-release eye therapies

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Alkeus Pharmaceuticals to present TEASE and SAGA study data at ASRS 2025
July 27th 2025

Alkeus Pharmaceuticals to present TEASE and SAGA study data at ASRS 2025

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA
July 26th 2025

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA

© 2025 MJH Life Sciences

All rights reserved.